"Insights from Supreme Court Abortion Pill Arguments"
TL;DR
During Supreme Court arguments, a majority of the justices seemed inclined to reject a bid to limit access to abortion pills, expressing doubts about the plaintiffs' standing and the potential nationwide implications of the case. The case centers on changes made by the FDA in 2016 and 2021, which broadened access to the drug mifepristone, allowing telemedicine prescriptions and mail delivery. Justices questioned the plaintiffs' remedy of applying nationwide restrictions, expressing concerns about second-guessing the FDA's regulatory authority.
Topics:nationlaw-and-politics#abortion-pill-access#fda#law-and-politics#medication-abortion#supreme-court#telemedicine
- Key Takeaways From Supreme Court Arguments on Abortion Pill Access The New York Times
- Takeaways from the Supreme Court arguments over the abortion drug mifepristone CNN
- The fear of going too far: Takeaways from the Supreme Court’s biggest abortion case since Dobbs POLITICO
- Periods, 'live tissue': Female justices get specific about women's health The Washington Post
- Erin Hawley: The Woman Arguing Against the Abortion Pill The New York Times
Want the full story? Read the original reporting
Read on The New York Times